KESHENG WU: Open Payments
NPI 1932119385 · WHITTIER, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$100 in 6 payments from 5 companies in 2025. Trend: 2023 $334 · 2024 $231 · 2025 $100
Food & beverage: $84Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Amgen Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Smith+Nephew, Inc. | 1 | $15 |
Products named: VERQUVO, REPATHA, BREZTRI, DALVANCE, COLLAGENASE SANTYL, TEFLARO.
Industry payments across CA — which companies pay providers there.
